Why the study?
Does halofantrine induce ventricular arrhythmias in patients with congenital long QT syndrome?
Does halofantrine induce ventricular arrhythmias in patients with congenital long QT syndrome?
Halofantrine can induce life-threatening arrhythmias such as torsade de pointes in patients with congenital long QT syndrome.
Answers are grounded in this paper and cite their sources.
Halofantrine may warrant caution in congenital LQTS; leaves open generalizability beyond case reports.
This report deals with two patients who suffered sustained episodes of torsade de pointes ventricular tachycardia while using the novel antimalarial drug halofantrine. Both patients had congenital long QT syndrome, and their QT interval was further prolonged at the time of the event. This first electrocardiographic documentation of ventricular arrhythmias together with halofantrine's known prolonging effect on the QT interval demonstrates that the drug has the potential to induce life-threatening arrhythmias.
No takes yet. Share an insight, caveat, or question.
Toivonen et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: